{"id":6134,"date":"2025-01-08T11:02:00","date_gmt":"2025-01-08T05:32:00","guid":{"rendered":"https:\/\/fidorehealth.com\/5-best-peppermint-essential-oil-for-hair\/"},"modified":"2025-10-29T13:20:32","modified_gmt":"2025-10-29T07:50:32","slug":"hair-fall-in-diabetics","status":"publish","type":"post","link":"https:\/\/fidorehealth.com\/blog\/hair-fall-in-diabetics\/","title":{"rendered":"Hair-fall In  Diabetics"},"content":{"rendered":"\n<figure class=\"wp-block-image aligncenter size-large is-resized\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"576\" src=\"https:\/\/fidorehealth.com\/blog\/wp-content\/uploads\/2025\/01\/Untitled-design-58-1024x576.png\" alt=\"Hair-fall In  Diabetics - details\" class=\"wp-image-7419\" style=\"width:678px;height:auto\" srcset=\"https:\/\/fidorehealth.com\/blog\/wp-content\/uploads\/2025\/01\/Untitled-design-58-1024x576.png 1024w, https:\/\/fidorehealth.com\/blog\/wp-content\/uploads\/2025\/01\/Untitled-design-58-300x169.png 300w, https:\/\/fidorehealth.com\/blog\/wp-content\/uploads\/2025\/01\/Untitled-design-58-768x432.png 768w, https:\/\/fidorehealth.com\/blog\/wp-content\/uploads\/2025\/01\/Untitled-design-58.png 1440w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n\n\n\n<p><strong>HbA1c &lt;7.5% (Mild hyperglycemia): it is Highly reversible <\/strong><\/p>\n\n\n\n<p><br>First-line therapy: Lifestyle modifications (diet and exercise) + Metformin. Metformin is the preferred initial drug of choice due to its efficacy, safety, and minimal risk of hypoglycemia ( Drop in Blood Glucose Level below Normal on Consuming) Follow-up: Assess response in 3 months. If HbA1c is still above target, consider dual therapy.<\/p>\n\n\n\n<p><br><strong>HbA1c 7.5%-8.9% (Moderate hyperglycemia):<\/strong><\/p>\n\n\n\n<p><br>Dual therapy: Metformin + second agent based on patient profile:<br>Sulfonylurea (e.g., glimepiride): If cost is a concern and no risk of hypoglycemia.<br>SGLT-2 inhibitors (e.g., empagliflozin): For cardiovascular or renal benefits.<br>DPP-4 inhibitors (e.g., sitagliptin): For weight neutrality and low hypoglycemia risk.<br>GLP-1 receptor agonists (Semaglutide): For added weight loss benefits.<br>GLP-1 RA , slows food passage through your Stomach , makes your brain think you are full &amp; you tend to consume less food = weight loss + control of Sugar as well (layman Expl.)<\/p>\n\n\n\n<p><br>Follow-up: Reassess HbA1c after 3 months. Adjust therapy if needed.<\/p>\n\n\n\n<p><br><strong>HbA1c \u22659% (Severe hyperglycemia):<\/strong><\/p>\n\n\n\n<p><br>Symptomatic or ketosis: Initiate insulin with or without OHAs.<br><strong>Non-symptomatic:<br><\/strong>Triple therapy with Metformin + two additional agents:<br>SGLT-2 inhibitor + DPP-4 inhibitor or<br>SGLT-2 inhibitor + sulfonylurea.<br>For weight loss, GLP-1 receptor agonists can replace one OHA.<br>Monitoring and Adjustments:<br>Monitor HbA1c every 3-6 months.<br>Adjust therapy based on HbA1c targets, side effects, and patient preferences.<\/p>\n\n\n\n<p><br><strong>Special Considerations:<\/strong><br>Elderly or frail: Use agents with low hypoglycemia risk (DPP-4 inhibitors or SGLT-2 inhibitors).<br>Obesity: Prefer GLP-1 receptor agonists or SGLT-2 inhibitors for weight management.<br>Cardiovasculardisease: PrioritizeSGLT2 inhibitors or GLP1 receptor agonists<\/p>\n","protected":false},"excerpt":{"rendered":"<p>HbA1c &lt;7.5% (Mild hyperglycemia): it is Highly reversible First-line therapy: Lifestyle modifications (diet and exercise) + Metformin. Metformin is the preferred initial drug of choice due to its efficacy, safety, and minimal risk of hypoglycemia ( Drop in Blood Glucose Level below Normal on Consuming) Follow-up: Assess response in 3 months. If HbA1c is still [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":7417,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-6134","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog"],"_links":{"self":[{"href":"https:\/\/fidorehealth.com\/blog\/wp-json\/wp\/v2\/posts\/6134","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/fidorehealth.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/fidorehealth.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/fidorehealth.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/fidorehealth.com\/blog\/wp-json\/wp\/v2\/comments?post=6134"}],"version-history":[{"count":5,"href":"https:\/\/fidorehealth.com\/blog\/wp-json\/wp\/v2\/posts\/6134\/revisions"}],"predecessor-version":[{"id":7423,"href":"https:\/\/fidorehealth.com\/blog\/wp-json\/wp\/v2\/posts\/6134\/revisions\/7423"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/fidorehealth.com\/blog\/wp-json\/wp\/v2\/media\/7417"}],"wp:attachment":[{"href":"https:\/\/fidorehealth.com\/blog\/wp-json\/wp\/v2\/media?parent=6134"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/fidorehealth.com\/blog\/wp-json\/wp\/v2\/categories?post=6134"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/fidorehealth.com\/blog\/wp-json\/wp\/v2\/tags?post=6134"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}